Rifabutin
Back to searchMolecule Structure
Scientific Name
Rifabutin
Description of the Drug
Rifabutin is an antibiotic used to treat mycobacterium avium complex disease in patients with HIV.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00615
http://www.drugbank.ca/drugs/DB00615
Brand Name(s)
Mycobutin, Rifabutin
Company Owner(s)
Redhill Biopharma Ltd, Novitium Pharma Llc, Pfizer Inc, Lupin Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial DNA-directed RNA polymerase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2364672 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL36043 | |
| PharmGKB | PA451249 | |
| DrugBank | DB00615 | |
| PubChem: Thomson Pharma | 14791636 | |
| LINCS | LSM-43193 | |
| Nikkaji | J342.306I | |
| PDBe | RBT | |
| BindingDB | 50237607 | |
| EPA CompTox Dashboard | DTXSID0033960 | |
| DrugCentral | 2376 | |
| Brenda | 135623 | |
| ChemicalBook | CB0702764 | |
| rxnorm | RIFABUTIN | MYCOBUTIN |
| PubChem: Drugs of the Future | 12012943 | |
| KEGG Ligand | C07235 | |
| ChEBI | 45367 | |
| ZINC | ZINC000169621215 |
